DIRECTOR DEALINGS: PureTech Health directors buy GBP176,000 in shares
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separately reported by Alliance News:
----------
Energean PLC - London-based energy company - Growthy Holdings Co Ltd, an entity closely associated with Chief Executive Officer Mathios Rigas, buys 26,299 shares at 703.10 pence each on Monday in London, for GBP184,908 in total. OilCo Investments Ltd, which is associated with Non-Executive Director Efstathios Topouzoglou, buys 26,195 shares at the same price, also in London on Monday, for GBP184,177. OilCo is owned by Trustena GmbH, the trustee of Topouzoglou's family trust 'The Energy Trust'.
----------
S&U PLC - Solihull, England-based lender focused on motor finance and property bridging - Chair Anthony Coombs sells 3,300 shares at 1,940p each for GBP64,020 on Thursday in London.
----------
PureTech Health PLC - Boston, Massachusetts-based biotech and pharmaceutical company - Directors buy 147,849 shares in total at 119p each, for GBP175,940, on Tuesday and Wednesday in London. Chief Executive Officer Robert Lyne acquires 36,500 shares; Interim Chair Sharon Barber-Lui buys 29,868; and Non-Executive Directors John LaMattina and Michele Holcomb buy 50,000 and 31,481 shares, respectively.
----------
By Emma Curzon, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
More In Markets
Markets Brief: Big-Tech Capex and What’s Next for the Yen
Investor Focus: Most-Shorted UK Stocks, Andy Burnham’s Pensions Plan, FTSE 100 AI Winners and Losers
